Psychedelic Research for Dementia Risks Perpetuating Structural Failures and Inadequacies in Aged Care
AJOB Neuroscience April 3, 2023 Hojjat Soofi, C. Forlini
Carhart-Harris, R., B. Giribaldi, R. Watts, M. Baker-Jones, A. Murphy-Beiner, R. Murphy, J. Martell, A. Blemings, D. Erritzoe, D. J. Nutt, et al. 2021. Trial of psilocybin versus escitalopram for depression. New England Journal of Medicine 384 (15):1402–11. doi:10.1056/NEJMoa 2032994. Coulson, A. 2023. Lecanemab approved for use by US FDA. NeuroCentral, 19 Jan. https://www.neuro-central.com/...